menu search

Three-stock lunch: enphase, fisker and teladoc

Payne Capital Management's Courtney Garcia joins 'Power Lunch' to discuss investment strategies for today's top movers: Enphase, Fisker, and Teladoc....

February 27, 2023, 3:24 pm

Uniqure announces 2022 financial results and highlights recent company progress

~ Achieved U.S. and European Commission marketing approvals of first and only gene therapyfor adults with hemophilia B ~ ~ Advancing development of AM...

February 27, 2023, 12:05 pm

Enphase energy ($enph) announces growing demand for iq8 microiverters in pennsylvania

Enphase Energy (NASDAQ: ENPH) has announced that the company is experiencing growing demand for its IQ8...

February 27, 2023, 11:22 am

Here is what to know beyond why enphase energy, inc. (enph) is a trending stock

Recently, Zacks.com users have been paying close attention to Enphase Energy (ENPH). This makes it wort...

February 27, 2023, 10:32 am

Canada silver cobalt works drills long nickel equivalent intersection near surface at graal property in quebec

Canada Silver Cobalt Works Inc (TSX-V:CCW, OTCQB:CCWOF) (CCW) announced that it has reviewed and verified the assay results from its ...

February 27, 2023, 10:15 am

South star battery set to achieve commercial production at santa cruz mine in brazil by end 2023

South Star Battery Metals Corp. (TSX-V:STS, OTCQB:STSBF) told investors it is set its Santa Cruz open-pit flake graphite mining project in Brazil int...

February 27, 2023, 9:41 am

Scholar rock to present at the cowen 43rd annual health care conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a phase 3 clinical-stage biopharmaceuti...

February 27, 2023, 8:00 am

Us dollar holds the high ground as inflation haunts markets. where to for usd?

The US Dollar ascendency got back on track last week after strong core US PCE data triggered fears of an even more aggressive Fed tightening phaser. W...

February 27, 2023, 4:30 am

Celldex therapeutics presents positive data from barzolvolimab phase 1b study in chronic spontaneous urticaria at aaaai 2023

– Rapid, profound and durable responses across multiple dosing groups with favorable safety profile observed—positioning barzolimab as a potential...

February 26, 2023, 2:00 pm

Actinium pharma cratered 37% over two days — here's why, according to ceo sandesh seth

Actinium has lofty ambitions to change the landscape of leukemia treatment. But ATNM stock cratered this week on final-...

February 24, 2023, 2:16 pm

Analysts holding as pfizer waits on two phase 3 studies

Pfizer Inc. (NYSE: PFE) may have ten blockbuster drugs in its pipeline, but it seems much of the company's near-term potential could be based on the s...

February 24, 2023, 9:06 am

Why is nektar therapeutics (nktr) stock down 39% today?

Nektar Therapeutics (NASDAQ: NKTR ) stock is taking a beating on Friday following the release of phase ...

February 24, 2023, 8:56 am

Nektar stock drops more than 30% after study involving lupus treatment will not go forward

Shares of Nektar Therapeutics NKTR, -1.66% plunged more than 30% in the extended session Thursday after the biopharma company reported that a study di...

February 23, 2023, 5:24 pm

Humana will phase out employer group business to focus on medicare and medicaid health plans

Humana will exit its employer group commercial medical products business" to focus on Medicaid and Medicare Advantage....

February 23, 2023, 9:29 am

Shiftcarbon to receive us$5m in revenue in first phase of partnership with saudi arabia's solutions by stc

ShiftCarbon (CSE:SHFT), formerly TraceSafe, has announced its first revenue-generating engagement with Saudi Arabian tech giant solutions by stc. The...

February 23, 2023, 9:04 am

Enbridge: pivotal buying moment

Despite having solid visibility over its cash flows, Enbridge is currently in the midst of a growth normalization phase. However, its NTM dividend yie...

February 22, 2023, 10:00 am

Chinook: travere's sparsentan approval is net positive

Travere's FILSPARI (sparsentan) received accelerated approval for IgAN's disease on Feb 17, 2023. Chinook has a similar ...

February 22, 2023, 2:26 am

Tnr gold repays investment loan; says operational phase begins at ganfeng's mariana lithium project in argentina

TNR Gold Corp (TSX-V:TNR, OTC:TRRXF) announced that it has repaid in full the existing long-term investment loan in the principal amount of C$6,943,23...

February 21, 2023, 12:58 pm

Medical device stock eyes worst day ever

CVRx Inc (NASDAQ:CVRX) stock is on track for its worst single session ever, down 43.3% to trade at $9.75 at last glance, after news that the medical ...

February 21, 2023, 10:53 am

Algernon pharmaceuticals says unit initiates traumatic brain injury research program with dmt; appoints global tbi expert as advisor

Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) said its subsidiary Algernon NeuroScience (AGN Neuro) has added a new clinical research program ...

February 21, 2023, 9:09 am


Search within

Pages Search Results: